These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9521275)

  • 1. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism.
    Herzog AG; Klein P; Jacobs AR
    Neurology; 1998 Mar; 50(3):782-4. PubMed ID: 9521275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive endocrine considerations and hormonal therapy for men with epilepsy.
    Herzog AG
    Epilepsia; 1991; 32 Suppl 6():S34-7. PubMed ID: 1959510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitors for male infertility.
    Raman JD; Schlegel PN
    J Urol; 2002 Feb; 167(2 Pt 1):624-9. PubMed ID: 11792932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone.
    Zumoff B; Miller LK; Strain GW
    Metabolism; 2003 Sep; 52(9):1126-8. PubMed ID: 14506617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
    Herzog AG; Farina EL; Drislane FW; Schomer DL; Smithson SD; Fowler KM; Dworetzky BA; Bromfield EB
    Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic efficacy of testolactone (aromatase inhibitor) to oligozoospermia with high estradiol/testosterone ratio].
    Itoh N; Kumamoto Y; Maruta H; Tsukamoto T; Takagi Y; Mikuma N; Nanbu A; Tachiki H
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):204-9. PubMed ID: 2041267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epilepsy and male sexual dysfunction: etiology, diagnosis and therapy].
    Bóné B; Janszky J
    Ideggyogy Sz; 2006 May; 59(5-6):148-52. PubMed ID: 16786709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover.
    Clark RV; Sherins RJ
    J Androl; 1989; 10(3):240-7. PubMed ID: 2663800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a treatable endocrinopathy in infertile men.
    Pavlovich CP; King P; Goldstein M; Schlegel PN
    J Urol; 2001 Mar; 165(3):837-41. PubMed ID: 11176482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
    Holbrook JM; Cohen PG
    South Med J; 2003 Jun; 96(6):544-7. PubMed ID: 12938779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia.
    Schweikert HU; Tunn UW
    Steroids; 1987; 50(1-3):191-200. PubMed ID: 2460975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone].
    Schill WB; Reiter F; Korting HC; Schweikert HU
    Hautarzt; 1987 Jul; 38(7):395-9. PubMed ID: 3115914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibition by delta 1-testolactone does not relieve the gonadotropin-induced late steroidogenic block in normal men.
    Smals AG; Dony JM; Smals AE; Pieters GF; Hermus AR; Boers GH; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1127-31. PubMed ID: 3923019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human male sexual functions do not require aromatization of testosterone: a study using tamoxifen, testolactone, and dihydrotestosterone.
    Gooren LJ
    Arch Sex Behav; 1985 Dec; 14(6):539-48. PubMed ID: 4084053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of treating male hypogonadism on couples' sexual desire and function.
    Conaglen JV; Conaglen HM
    J Sex Med; 2009 Feb; 6(2):456-63. PubMed ID: 19215616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologically induced hypogonadism and sexual function in healthy young women and men.
    Schmidt PJ; Steinberg EM; Negro PP; Haq N; Gibson C; Rubinow DR
    Neuropsychopharmacology; 2009 Feb; 34(3):565-76. PubMed ID: 18354393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility.
    Del Giudice F; Busetto GM; De Berardinis E; Sperduti I; Ferro M; Maggi M; Gross MS; Sciarra A; Eisenberg ML
    Asian J Androl; 2020; 22(4):360-367. PubMed ID: 31621654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
    Mechlin CW; Frankel J; McCullough A
    J Sex Med; 2014 Jan; 11(1):254-61. PubMed ID: 24119010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of supraphysiologic doses of testosterone on fasting total homocysteine levels in normal men.
    Zmuda JM; Bausserman LL; Maceroni D; Thompson PD
    Atherosclerosis; 1997 Apr; 130(1-2):199-202. PubMed ID: 9126665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.